| Cash Flow | 2025-06-30 |
|---|---|
| Non-cash compensation | 14,749 |
| Net income | 90,873 |
| Other current assets | -3,576 |
| Other assets | -48 |
| Other long-term obligations | -34 |
| Operating lease liabilities | -15,248 |
| Accrued expenses | -15,666 |
| Patient accounts receivable | -554 |
| Accounts payable | -9,805 |
| Equity in earnings from equity method investments | 3,435 |
| Gain on disposal of property and equipment | 45 |
| Gain on equity method investment | 48,093 |
| Return on equity method investments | 3,379 |
| Depreciation and amortization (inclusive of depreciation included in cost of service) | 13,488 |
| Deferred income taxes | 16,395 |
| Impairment | 883 |
| Amortization of deferred debt issuance costs | 442 |
| Operating lease right of use assets | -2,364 |
| Gain on termination of joint venture | 3,568 |
| Amortization and impairment of operating lease right of use assets | 17,395 |
| Net cash provided by operating activities | 63,524 |
| Proceeds from the sale of deferred compensation plan assets | 27 |
| Proceeds from the sale of property and equipment | 19 |
| Investments in technology assets | 426 |
| Purchases of property and equipment | 1,915 |
| Investment in equity method investee | 0 |
| Net cash used in investing activities | -2,295 |
| Principal payments of long-term obligations | 19,552 |
| Proceeds from issuance of stock upon exercise of stock options | 149 |
| Noncontrolling interest contributions | 0 |
| Shares withheld to pay taxes on non-cash compensation | 6,005 |
| Debt issuance costs | 499 |
| Noncontrolling interest distributions | 1,260 |
| Net cash used in financing activities | -27,167 |
| Net increase in cash, cash equivalents and restricted cash | 34,062 |
AMEDISYS INC (AMED)
AMEDISYS INC (AMED)